BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 18728000)

  • 1. Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV).
    Li M; Ding W; Baruah B; Crans DC; Wang R
    J Inorg Biochem; 2008 Oct; 102(10):1846-53. PubMed ID: 18728000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin.
    Bordbar AK; Creagh AL; Mohammadi F; Haynes CA; Orvig C
    J Inorg Biochem; 2009 Apr; 103(4):643-7. PubMed ID: 19056126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component.
    Peters KG; Davis MG; Howard BW; Pokross M; Rastogi V; Diven C; Greis KD; Eby-Wilkens E; Maier M; Evdokimov A; Soper S; Genbauffe F
    J Inorg Biochem; 2003 Aug; 96(2-3):321-30. PubMed ID: 12888267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of bis(maltolato)oxovanadium(IV)-induced insulin signaling in 3T3-L1 and IM9 cells: impact of dexamethasone.
    Bose S; Farah MA; Jung HC; Lee JH; Kim Y
    J Mol Endocrinol; 2007 Jun; 38(6):627-49. PubMed ID: 17556533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo.
    Mohammad A; Wang J; McNeill JH
    Mol Cell Biochem; 2002 Jan; 229(1-2):125-8. PubMed ID: 11936837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
    Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
    Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
    Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
    Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains.
    Winter PW; Al-Qatati A; Wolf-Ringwall AL; Schoeberl S; Chatterjee PB; Barisas BG; Roess DA; Crans DC
    Dalton Trans; 2012 Jun; 41(21):6419-30. PubMed ID: 22569684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
    Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
    Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutant.
    Skorey KI; Kennedy BP; Friesen RW; Ramachandran C
    Anal Biochem; 2001 Apr; 291(2):269-78. PubMed ID: 11401301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
    Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
    Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of the protein tyrosine phosphatase 1B inhibitory metabolite from the marine-derived fungus Cosmospora sp. SF-5060.
    Seo C; Sohn JH; Oh H; Kim BY; Ahn JS
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6095-7. PubMed ID: 19782562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of BMOV in the presence of blood serum proteins.
    Sanna D; Bíró L; Buglyó P; Micera G; Garribba E
    Metallomics; 2012 Jan; 4(1):33-6. PubMed ID: 22094980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxovanadium-based inhibitors can drive redox-sensitive cytotoxicity in neuroblastoma cells and synergise strongly with buthionine sulfoximine.
    Clark O; Park I; Di Florio A; Cichon AC; Rustin S; Jugov R; Maeshima R; Stoker AW
    Cancer Lett; 2015 Feb; 357(1):316-327. PubMed ID: 25444896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
    Jindal S; Singh M; Balakumar P
    Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.
    Marzban L; Rahimian R; Brownsey RW; McNeill JH
    Endocrinology; 2002 Dec; 143(12):4636-45. PubMed ID: 12446591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis(maltolato)oxovanadium(IV) (BMOV) Attenuates Apoptosis in High Glucose-Treated Cardiac Cells and Diabetic Rat Hearts by Regulating the Unfolded Protein Responses (UPRs).
    Cong XQ; Piao MH; Li Y; Xie L; Liu Y
    Biol Trace Elem Res; 2016 Oct; 173(2):390-8. PubMed ID: 26983714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and morphological alterations in rat liver Golgi complexes after treatment with bis(maltolato)oxovanadium(IV) [BMOV] or maltol alone.
    Dabroś W; Dziga D; Gryboś R; Kordowiak AM
    Pathol Res Pract; 2000; 196(8):561-8. PubMed ID: 10982019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.